Survival after community diagnosis of early-stage non-small cell lung cancer
- PMID: 24486286
- PMCID: PMC4601577
- DOI: 10.1016/j.amjmed.2013.12.023
Survival after community diagnosis of early-stage non-small cell lung cancer
Abstract
Background: "Rush to surgery" among patients with worse symptoms, delays related to morbidity, and inclusion of patients with advanced disease in study populations have produced a mixed picture of importance of time to treatment to survival of non-small cell lung cancer. Our objective was to assess the contribution of diagnosis to first surgery interval to survival among patients diagnosed in the community with early-stage non-small cell lung cancer.
Methods: Patients with early-stage lung cancer (N = 174) at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins who were diagnosed and treated from 2003 to 2009 and followed through 2011 made up a prospective study of overall survival. Diagnosis to first surgery interval was examined overall, as 2 segments (referral interval and treatment interval), as short and longer intervals, and as a continuous variable.
Results: The majority of patients were female (55%) and aged more than 65 years (61%). The average mean referral and treatment delays were 61.2 and 5.9 days, respectively. Cox method hazard analysis revealed that older age (years) at diagnosis (hazard ratio [HR], 1.02; 95% confidence interval [CI], 1.00-1.05), stage IIB (HR, 2.17; 95% CI, 1.12-4.21), large (>4 cm) (HR, 3.68; 95% CI, 1.05-12.93) or unknown tumor size (HR, 4.45; 95% CI, 1.21-16.38), and weeks from diagnosis to first surgery interval (HR, 1.04; 95% CI, 1.00-1.09) predicted worse overall survival. The threshold period of less than 42 days from diagnosis to surgery did not reach statistical significance.
Conclusions: Patients seem to benefit from rapid reduction of tumor burden with surgery. Reasons for delay were not available. Nevertheless, referral delay experienced in the community is unduly long. In addition to patient choices, an unconscious patient or physician bias that lung cancer is untreatable or an inevitable consequence of smoking may be operating and needs further investigation.
Keywords: Lung; Lung cancer biology; Lung cancer surgery; Quality care management; Statistics; Survival analysis.
Copyright © 2014. Published by Elsevier Inc.
Conflict of interest statement
Figures
Similar articles
-
Time to surgery in early-stage non-small cell lung cancer: Defining the optimal diagnosis-to-resection interval to reduce mortality.J Thorac Cardiovasc Surg. 2025 Jun;169(6):1563-1572.e5. doi: 10.1016/j.jtcvs.2024.11.040. Epub 2024 Dec 16. J Thorac Cardiovasc Surg. 2025. PMID: 39674315
-
Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.JAMA Netw Open. 2019 Nov 1;2(11):e1915724. doi: 10.1001/jamanetworkopen.2019.15724. JAMA Netw Open. 2019. PMID: 31747032 Free PMC article.
-
Differences in outcomes between younger and older patients with non-small cell lung cancer.Ann Thorac Surg. 2008 May;85(5):1735-9; discussion 1739. doi: 10.1016/j.athoracsur.2008.01.031. Ann Thorac Surg. 2008. PMID: 18442575
-
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results.Br J Cancer. 2006 Jul 17;95(2):139-45. doi: 10.1038/sj.bjc.6603226. Epub 2006 Jun 20. Br J Cancer. 2006. PMID: 16786043 Free PMC article.
-
How long is too long? A scoping review of health system delays in lung cancer.Eur Respir Rev. 2018 Aug 29;27(149):180045. doi: 10.1183/16000617.0045-2018. Print 2018 Sep 30. Eur Respir Rev. 2018. PMID: 30158277 Free PMC article.
Cited by
-
Delayed surgery after histologic or radiologic-diagnosed clinical stage I lung adenocarcinoma.J Thorac Dis. 2020 Mar;12(3):615-625. doi: 10.21037/jtd.2019.12.123. J Thorac Dis. 2020. PMID: 32274127 Free PMC article.
-
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.Thorax. 2022 Aug;77(8):762-768. doi: 10.1136/thoraxjnl-2021-216865. Epub 2021 Aug 17. Thorax. 2022. PMID: 34404753 Free PMC article.
-
Survival analysis and clinicopathological features of patients with stage IA lung adenocarcinoma.Heliyon. 2023 Dec 6;10(1):e23205. doi: 10.1016/j.heliyon.2023.e23205. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38169765 Free PMC article.
-
Death by a thousand delays.JTCVS Open. 2024 Jan 10;18:353-359. doi: 10.1016/j.xjon.2024.01.005. eCollection 2024 Apr. JTCVS Open. 2024. PMID: 38690410 Free PMC article. No abstract available.
-
Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients.Mol Clin Oncol. 2017 Sep;7(3):498-506. doi: 10.3892/mco.2017.1342. Epub 2017 Jul 24. Mol Clin Oncol. 2017. PMID: 28811903 Free PMC article.
References
-
- Ettinger DS, Kris MG. NCCN: Non-small cell lung cancer. Cancer Control. 2001;8:22–31. - PubMed
-
- Harless W, Qiu Y. Cancer: a medical emergency. Med Hypotheses. 2006;67:1054–1059. - PubMed
-
- Gould MK, Ghaus SJ, Olsson JK, Schultz EM. Timeliness of care in veterans with non-small cell lung cancer. Chest. 2008;133:1167–1173. - PubMed
-
- Aragoneses FG, Moreno N, Leon P, Fontan EG, Folque E. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer. 2002;36:59–63. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical